Deglycosylated Antibody Clears Amyloid Plaques in Mice
Author Information
Author(s): Niki Carty, Donna M Wilcock, Arnon Rosenthal, Jan Grimm, Jaume Pons, Victoria Ronan, Paul E Gottschall, Marcia N Gordon, Dave Morgan
Primary Institution: University of South Florida
Hypothesis
Can a deglycosylated anti-Aβ antibody clear amyloid plaques without activating microglia?
Conclusion
The deglycosylated 2H6 antibody can effectively remove amyloid plaques without triggering microglial activation.
Supporting Evidence
- The deglycosylated antibody showed reduced binding to Fcγ receptors, indicating lower immune activation.
- Both antibody types significantly reduced amyloid plaque load in treated mice.
- Microglial activation was significantly lower in mice treated with the deglycosylated antibody compared to the intact antibody.
Takeaway
Researchers found that a special type of antibody can clean up brain plaques linked to Alzheimer's without causing inflammation.
Methodology
Transgenic mice were injected with either deglycosylated or intact anti-Aβ antibodies, and brain tissues were analyzed for amyloid deposition and microglial responses.
Potential Biases
Potential bias due to the involvement of authors in the company that developed the antibodies.
Limitations
The study was limited to specific mouse models and may not fully represent human Alzheimer's disease.
Participant Demographics
Transgenic mice aged 13 and 20 months.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website